S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
Top-Rated Stocks  
NASDAQ:NTRA

Natera - NTRA News Today

$56.65
+0.95 (+1.71%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$54.32
▼
$56.72
50-Day Range
$39.72
▼
$58.29
52-Week Range
$27.35
▼
$59.75
Volume
917,175 shs
Average Volume
1.44 million shs
Market Capitalization
$6.42 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$79.27
Get Natera News Delivered to You Automatically

Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter.


NTRA Media Mentions By Week

NTRA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NTRA
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

NTRA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NTRA Articles
This Week
▼
3

4
▲
NTRA Articles
Average Week

SourceHeadline
marketbeat.com logoMichael Burkes Brophy Sells 651 Shares of Natera, Inc. (NASDAQ:NTRA) Stock
marketbeat.com - March 24 at 10:25 PM
marketbeat.com logoAssenagon Asset Management S.A. Has $26.69 Million Stake in Natera, Inc. (NASDAQ:NTRA)
marketbeat.com - March 22 at 5:28 AM
marketbeat.com logoNatera, Inc. (NASDAQ:NTRA) Given Average Recommendation of "Moderate Buy" by Brokerages
marketbeat.com - March 20 at 2:15 AM
businesswire.com logoNew Publication Demonstrates Utility of Natera’s Signatera™ Test in Melanoma
businesswire.com - March 22 at 8:10 AM
finance.yahoo.com logoNatera Announces Commercial Payor Coverage for Signatera™
finance.yahoo.com - March 2 at 11:38 AM
finance.yahoo.com logoNatera Appoints Ruth E. Williams-Brinkley to its Board of Directors
finance.yahoo.com - February 23 at 11:23 AM
finance.yahoo.com logoNatera Announces Fourth Quarter and Fiscal 2022 Earnings Conference Call
finance.yahoo.com - February 21 at 11:15 AM
finance.yahoo.com logoMedicare Extends Coverage of Natera’s Signatera™ MRD Test to Breast Cancer
finance.yahoo.com - February 16 at 8:41 AM
finance.yahoo.com logoNatera's (NASDAQ:NTRA) investors will be pleased with their fantastic 394% return over the last five years
finance.yahoo.com - February 4 at 10:17 AM
wsj.com logoNew Paper Highlights Clinical Utility of Natera's Renasight(TM) Test in the Management of Kidney Disease
wsj.com - February 3 at 8:28 AM
finance.yahoo.com logoNew Paper Highlights Clinical Utility of Natera’s Renasight™ Test in the Management of Kidney Disease
finance.yahoo.com - February 2 at 10:47 AM
finance.yahoo.com logoNew Signatera™ MRD Data in Gastrointestinal Cancers to be Presented at the ASCO GI Symposium 2023
finance.yahoo.com - January 19 at 10:17 AM
finance.yahoo.com logoNatera Announces Publication of Prospective, Multi-Site CIRCULATE Study in Nature Medicine Demonstrating Signatera’s Ability to Predict Chemotherapy Benefit in Colorectal Cancer
finance.yahoo.com - January 17 at 9:32 AM
finance.yahoo.com logoWall Street Analysts Think Natera (NTRA) Could Surge 82.88%: Read This Before Placing a Bet
finance.yahoo.com - January 12 at 3:38 PM
finance.yahoo.com logoNatera to Webcast Live Presentation at the 41st Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 3 at 8:13 PM
finance.yahoo.com logoA Natera, Inc. (NASDAQ:NTRA) insider increased their holdings by 13% last year
finance.yahoo.com - January 3 at 10:12 AM
finance.yahoo.com logoNatera Supports Updated ISHLT Guidelines for the Care of Heart Transplant Patients
finance.yahoo.com - December 22 at 12:26 AM
finance.yahoo.com logoNatera Announces Publication of Multi-Center Study Validating Signatera's Ability to Predict Recurrence in Esophageal and Gastric Cancers
finance.yahoo.com - December 9 at 8:45 AM
finance.yahoo.com logoNatera to Present New Signatera™ and Empower™ Data at the 2022 Annual San Antonio Breast Cancer Symposium
finance.yahoo.com - December 7 at 2:14 PM
finance.yahoo.com logoAfter losing 58% in the past year, Natera, Inc. (NASDAQ:NTRA) institutional owners must be relieved by the recent gain
finance.yahoo.com - December 7 at 2:14 PM
finance.yahoo.com logoNatera Announces Publication of Clinical Experience Study with 18,984 Twin Pregnancies Supporting Excellent Performance of Panorama™ NIPT
finance.yahoo.com - December 6 at 6:42 AM
finance.yahoo.com logoNatera to Participate in the Piper Sandler 34th Annual Healthcare Conference
finance.yahoo.com - November 23 at 10:55 AM
finance.yahoo.com logoNew Published Study Further Demonstrates the Ability of Natera's mPCR Technology to Monitor Immunotherapy Response in Metastatic Uveal Melanoma Patients
finance.yahoo.com - November 21 at 12:20 PM
finance.yahoo.com logoNatera Third Quarter 2022 Earnings: Beats Expectations
finance.yahoo.com - November 10 at 11:00 PM
finance.yahoo.com logoNatera Reports Third Quarter 2022 Financial Results
finance.yahoo.com - November 8 at 6:08 PM
finance.yahoo.com logoNatera (NTRA) Shares Outperformed in the Third Quarter on Positive Business Updates
finance.yahoo.com - November 4 at 11:15 AM
finance.yahoo.com logoNatera Awarded National MRD Testing Contract by the U.S. Department of Veterans Affairs
finance.yahoo.com - November 2 at 6:11 PM
finance.yahoo.com logoNatera to Report its Third Quarter 2022 Results on November 8th
finance.yahoo.com - November 1 at 2:31 PM
finance.yahoo.com logoNatera to Participate in Credit Suisse 31st Annual Healthcare Conference
finance.yahoo.com - November 1 at 2:31 PM
finance.yahoo.com logoNatera, Inc. (NTRA)
finance.yahoo.com - October 26 at 2:34 PM
nasdaq.com logoNTRA December 16th Options Begin Trading - Nasdaq
nasdaq.com - October 17 at 4:39 PM
proactiveinvestors.com logoNaturally Splendid says Denny's renews agreement to provide Plantein plant-based Nuggets and Crumbed Tenders at all its restaurants across Canada - Proactive Investors USA
proactiveinvestors.com - October 12 at 10:45 AM
seekingalpha.com logoNatera: Cracks In The Bearish Trade
seekingalpha.com - October 11 at 2:38 PM
reuters.com logoQuest Diagnostics agrees to settlement of DNA-test patent dispute - Reuters
reuters.com - October 10 at 3:46 PM
finance.yahoo.com logoNew Publication Validates Performance of Natera's Signatera™ MRD Test in Ovarian Cancer
finance.yahoo.com - October 6 at 9:07 AM
seekingalpha.com logoNatera gains on publication of data on transplant rejection assessment test (NASDAQ:NTRA) - Seeking Alpha
seekingalpha.com - October 4 at 9:16 PM
streetinsider.com logoNatera (NTRA) Reports Study Showing Prospera Kidney dd-cfDNA Test Outperforms DSA in Predicting Antibody Mediated Rejection - StreetInsider.com
streetinsider.com - October 4 at 4:16 PM
finance.yahoo.com logoNatera Announces 2025 ESG Goals with Publication of 2021 Report
finance.yahoo.com - September 29 at 1:03 PM
benzinga.com logoNatera (NASDAQ:NTRA) – Natera Presents New Colorectal And Breast Cancer Data From The CIRCULATE-Japan Stu - Benzinga
benzinga.com - September 12 at 3:43 PM
finance.yahoo.com logoNatera Presents New Colorectal and Breast Cancer Data at ESMO 2022, Highlighting Signatera's Ability to Inform Treatment Decisions in the Adjuvant and Neoadjuvant Settings
finance.yahoo.com - September 12 at 10:43 AM
reuters.com logoNTRA.O - Natera Inc | Stock Price & Latest News | Reuters
reuters.com - September 8 at 12:00 PM
benzinga.com logoNatera Inc (NTRA) – Natera to Participate in Upcoming Investor Conferences - Benzinga
benzinga.com - September 6 at 6:04 PM
nasdaq.com logoIs Natera (NASDAQ:NTRA) Using Too Much Debt? - Nasdaq
nasdaq.com - September 5 at 6:14 PM
finance.yahoo.com logoHereditary Testing Market (Size, Volume, Share & Trends) — Report Comparison by Rating, ToC, Page Count, and Price only at Douglas Insights - Yahoo Finance
finance.yahoo.com - September 1 at 9:24 PM
reuters.com logoNTRA.OQ - Natera Inc | Stock Price & Latest News | Reuters
reuters.com - August 28 at 10:33 PM
nasdaq.com logoFirst Week of April 2023 Options Trading For Natera - Nasdaq
nasdaq.com - August 25 at 10:49 PM
benzinga.com logoBenzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 - Benzinga
benzinga.com - August 25 at 5:48 PM
finance.yahoo.com logoNatera Earns Great Place to Work Certification™ for Second Consecutive Year
finance.yahoo.com - August 25 at 12:48 PM
thestreet.com logoThis Unpopular Move Could Save Invitae - TheStreet
thestreet.com - August 19 at 6:21 PM
finance.yahoo.com logoNatera Announces Enrollment Completion for RenaCARE Study
finance.yahoo.com - August 11 at 4:02 PM
finance.yahoo.com logoNatera Announces Q-Sub Filing with FDA for its Panorama® NIPT
finance.yahoo.com - August 10 at 8:41 PM
benzinga.com logoUnited Kingdom Non-Invasive Prenatal Testing Market Report 2022-2028 Featuring Natera, NIPD Genetics, You - Benzinga
benzinga.com - August 10 at 3:40 PM
seekingalpha.com logoNatera, Inc. (NTRA) CEO Steve Chapman on Q2 2022 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 6 at 10:14 PM
Get Natera News Delivered to You Automatically

Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:NTRA) was last updated on 3/24/2023 by MarketBeat.com Staff